Anthropometric Measures, Cardiovascular Outcomes, and Treatment Effects of Finerenone in Cardiovascular-Kidney-Metabolic Disease: Pooled Participant-Level Analysis of 3 Global Trials.

Ostrominski JW, Harrington J, Claggett BL, Filippatos G, Desai AS, Jhund PS, Henderson AD, Lam CSP, Senni M, Shah SJ, Voors AA, Zannad F, Rossing P, Ruilope LM, Anker SD, Pitt B, Agarwal R, Brinker MD, Rohwedder K, Lay-Flurrie J, Lage A, McMurray JJV, Solomon SD, Vaduganathan M

Open source

DOI: 10.1016/j.jacc.2025.08.039
Published: 2025 Nov 18
Container: Journal of the American College of Cardiology
Publisher: Not recorded
Open access: no

Credibility signals

limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

cautionDOI registered: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
cautionDOI resolves: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredOpen access status: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1016/j.jacc.2025.08.039,
  title = {Anthropometric Measures, Cardiovascular Outcomes, and Treatment Effects of Finerenone in Cardiovascular-Kidney-Metabolic Disease: Pooled Participant-Level Analysis of 3 Global Trials.},
  author = {Ostrominski JW and Harrington J and Claggett BL and Filippatos G and Desai AS and Jhund PS and Henderson AD and Lam CSP and Senni M and Shah SJ and Voors AA and Zannad F and Rossing P and Ruilope LM and Anker SD and Pitt B and Agarwal R and Brinker MD and Rohwedder K and Lay-Flurrie J and Lage A and McMurray JJV and Solomon SD and Vaduganathan M},
  year = {2025},
  journal = {Journal of the American College of Cardiology},
  doi = {10.1016/j.jacc.2025.08.039},
  url = {https://doi.org/10.1016/j.jacc.2025.08.039}
}

RIS

TY  - JOUR
TI  - Anthropometric Measures, Cardiovascular Outcomes, and Treatment Effects of Finerenone in Cardiovascular-Kidney-Metabolic Disease: Pooled Participant-Level Analysis of 3 Global Trials.
AU  - Ostrominski JW
AU  - Harrington J
AU  - Claggett BL
AU  - Filippatos G
AU  - Desai AS
AU  - Jhund PS
AU  - Henderson AD
AU  - Lam CSP
AU  - Senni M
AU  - Shah SJ
AU  - Voors AA
AU  - Zannad F
AU  - Rossing P
AU  - Ruilope LM
AU  - Anker SD
AU  - Pitt B
AU  - Agarwal R
AU  - Brinker MD
AU  - Rohwedder K
AU  - Lay-Flurrie J
AU  - Lage A
AU  - McMurray JJV
AU  - Solomon SD
AU  - Vaduganathan M
PY  - 2025
JO  - Journal of the American College of Cardiology
DO  - 10.1016/j.jacc.2025.08.039
UR  - https://doi.org/10.1016/j.jacc.2025.08.039
ER  -

APA

JW, O., J, H., BL, C., G, F., AS, D., PS, J., AD, H., CSP, L., M, S., SJ, S., AA, V., F, Z., P, R., LM, R., SD, A., B, P., R, A., MD, B., K, R., J, L., A, L., JJV, M., SD, S., & M, V. (2025). Anthropometric Measures, Cardiovascular Outcomes, and Treatment Effects of Finerenone in Cardiovascular-Kidney-Metabolic Disease: Pooled Participant-Level Analysis of 3 Global Trials.. Journal of the American College of Cardiology. https://doi.org/10.1016/j.jacc.2025.08.039

Source records

pubmed · retrieved 2026-09-25T22:16:51.884Z
europe-pmc · retrieved 2026-09-25T22:16:51.900Z
hal · retrieved 2026-09-25T22:16:51.939Z